The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO.
 
Gareth Owen Griffiths
Honoraria - Abbvie; AstraZeneca
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); BionTEch (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Heartflow (Inst); Heartflow (Inst); Jannsenn-Cilag (Inst); Novartis (Inst); Roche (Inst)
 
Daniel Griffiths
No Relationships to Disclose
 
Zina Eminton
No Relationships to Disclose
 
Kayleigh Hill
No Relationships to Disclose
 
Charlotte Poile
Research Funding - Boehringer Ingelheim
 
Mavis Nye
No Relationships to Disclose
 
Judith Cave
Travel, Accommodations, Expenses - Amgen; Roche
 
Sarah Danson
No Relationships to Disclose
 
Elizabeth Toy
Honoraria - AstraZeneca; Lilly O.; MSD; Pfizer; Roche
 
Pooja Jain
No Relationships to Disclose
 
Nicola Steele
No Relationships to Disclose
 
Paul Shaw
No Relationships to Disclose
 
Paul Taylor
Stock and Other Ownership Interests - Roche/Genentech
Speakers' Bureau - AstraZeneca
Research Funding - Bayer; Epizyme
 
Peter Wojciech Szlosarek
No Relationships to Disclose
 
Dionysis Papadatos-Pastos
No Relationships to Disclose
 
Liz Darlison
No Relationships to Disclose
 
Dean Anthony Fennell
Honoraria - Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Inventiva Pharma; Novocure; RS Oncology; targovax
Consulting or Advisory Role - Bristol-Myers Squibb; Inventiva Pharma; Novocure; Roche; Targovax
Speakers' Bureau - BMS; Boehringer Ingelheim
Research Funding - Astex Pharmaceuticals; Bayer; Boehringer Ingelheim (Inst); Bristol Myers Squbb (Inst); Fuji Pharma (Inst); lab21 (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology